Consult QD catches up with Matthew Kroh, MD, Chairman of the Digestive Disease Institute at Cleveland Clinic Abu Dhabi, who talks about the significantly expanded size and scope of this Center of Excellence and the new programs and services that are addressing the Middle East’s medical needs.
Laparoscopic RYGB may become the preferred approach to decrease acid and bile reflux and preserve esophageal function in scleroderma patients.
Attend the 12th Annual Cleveland Clinic Obesity Summit, Sept. 28-29, to hear about pharmacologic management, behavioral and lifestyle modification, and surgery.
Cleveland Clinic Abu Dhabi’s Digestive Disease Institute is seeing a 30 percent increase in volumes year over year. Chief Matthew Kroh, MD, explains efforts to provide the highest quality digestive disease services in the Middle East.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Per oral endoscopic pyloromyotomy (POP) has become our first-line treatment for medically refractory gastoparesis in well selected patients. John Rodriguez, MD, explains.
Digestive Disease & Surgery Institute Chairman Conor Delaney, MD, PhD, explains why Cleveland Clinic is committed to providing digestive disease services in Abu Dhabi in our “Short Answer” series.
Matthew Kroh views his new role as Chief of the Digestive Disease Institute at Cleveland Clinic Abu Dhabi as growing its dynamic clinical programs and expanding to encompass Cleveland Clinic’s core missions of education and research.
Find out how a team of physicians collaborated across continents to perform the first POEM procedure in the Middle East, using a cutting-edge endoscopic technique to treat achalasia.
For patients with gastroparesis, relief from nausea, vomiting and bloating seemed impossible. A new clinic uses multidisciplinary treatment and endoscopic technology to offer hope and symptom relief.
Cleveland Clinic is among the first centers in the nation to offer access to a balloon device to provide a non-surgical treatment option for obese patients whose previous attempts at weight loss through diet and exercise failed.